We are so proud of Dr. Jeff Infante, former Tennessee Oncology physician and key investigator for the Drug Development Unit at Sarah Cannon Research
Posted on January 25, 2022
Dr. Infante is now Global Head of Oncology Early Development and Transitional Research for Janssen Pharmaceutical Company of Johnson & Johnson. In his role he leads a team of physicians and scientists from around the world that design new cancer treatments and develop new cancer drugs. Dr. Infante returned to Tennessee Oncology last year to film at locations where his bedside work with cancer patients inspired him to develop and dedicate his life to new therapies. Every day he is working tirelessly towards eradicating cancer for all and he is certainly an inspiration to us.